Search for: "DAIICHI PHARMACEUTICALS,INC."
Results 41 - 60
of 83
Sort by Relevance
|
Sort by Date
1 Dec 2012, 8:00 pm
Separately, as to Ranbaxy's version of Lipitor ( atorvastatin ), note text from BusinessWeek in the postDrugmaker Ranbaxy halts generic Lipitor production : Problem-plagued Ranbaxy Pharmaceuticals Inc. has halted production of generic cholesterol drug Lipitor while it investigates how tiny glass particles got into the ingredients used for dozens of batches of the drug that were recalled in November. [read post]
1 Dec 2012, 8:00 pm
Separately, as to Ranbaxy's version of Lipitor ( atorvastatin ), note text from BusinessWeek in the postDrugmaker Ranbaxy halts generic Lipitor production : Problem-plagued Ranbaxy Pharmaceuticals Inc. has halted production of generic cholesterol drug Lipitor while it investigates how tiny glass particles got into the ingredients used for dozens of batches of the drug that were recalled in November. [read post]
1 Dec 2011, 3:58 am
As one can see, the big price break for this statin is 6 months from today.Ranbaxy is 64 percent-owned by Daiichi Sankyo Co. [read post]
20 Nov 2011, 7:01 am
©2011 Amaxx Risk Solutions, Inc. [read post]
22 Jul 2011, 12:06 am
She is suing Johnson & Johnson, Ortho-McNeil Pharmaceutical Inc. and Johnson & Johnson Pharmaceutical Research & Development LLC for negligence, breach of warranties and consumer fraud. [read post]
6 Jul 2011, 2:21 am
Biopet Vet Lab, Inc., et. al. [read post]
1 May 2011, 8:45 pm
Daiichi Sankyo Inc. et al. v. [read post]
14 Mar 2011, 8:12 pm
Daiichi Sankyo Co., Ltd.Docket: 10-770Issue(s): Whether, contrary to this Court's decision in KSR International Co. v. [read post]
9 Mar 2011, 3:00 am
Bayer AG (FDA Law Blog) (Patent Docs) Dexilant (Dexlansoprazole) – US: Takeda files patent infringement suit against Handa following Para IV certification filing (Patent Docs) EpiPen – US: Orange Book patent delisting counterclaim raised in 505(b)(2) application patent infringement litigation; decision could provide guidance on drug delivery system patent listability: King Pharmaceuticals v Intelliject (FDA Law Blog) Fentora (Fentanyl) – US: Cephalon files… [read post]
8 Feb 2011, 10:51 pm
(FDA Law Blog) US: Another academic with solutions to problems that don’t exist (Patent Docs) US: Syngenta files for declaratory judgment of invalidity and non-infringement of Bayer’s patents based on its development of GM crops containing HPPD gene (Patent Docs) US: District Court New Jersey: Loss of market share to infringing competitor during six year reexamination warrants denial of stay: Wyeth et al v Abbott (Docket Report) US: District Court New Jersey: Court precludes jury… [read post]
5 Jan 2011, 8:54 am
On December 21, 2010, a former employee of drug company, Daiichi Sankyo, Inc. filed a lawsuit alleging that Daiichi misclassified pharmaceutical sales representatives (“Sales Reps”) as exempt employees thereby improperly denying them overtime under the Fair Labor Standards Act (“FLSA”). [read post]
8 Dec 2010, 2:20 am
Highlights this week included: India: Supreme Court dismisses Bayer’ petition in patent linkage matter (Generic Pharmaceuticals and IP) (Spicy IP) (GenericsWeb) (SiNApSE) Please join the discussion by adding your comments on any of these stories, and please do let us know if you think we’ve missed something important, or if there is a source you think should be monitored. [read post]
13 Sep 2010, 9:59 pm
Matrix Laboratories, Ltd., decided last Thursday, the Federal Circuit affirmed a determination by the District Court for the District of New Jersey that Matrix Laboratories, Ltd., Mylan Inc., Mylan Laboratories, Inc., and Mylan Pharmaceuticals, Inc. [read post]
9 Sep 2010, 7:09 pm
Zenith Goldline Pharmaceuticals, Inc., 471 F.3d 1369, 1377-79 (Fed. [read post]
25 Aug 2010, 12:37 am
Watson Pharma, Inc. et al. [read post]
10 Aug 2010, 8:44 pm
Highlights this week included: CAFC: Genus-species; doctrine of equivalents; and patentable subject matter: Intervet v Merial Limited (Patently-O) (Holman’s Biotech IP Blog) (IP Spotlight) (IPBiz) (Patent Docs) Angiomax (Bivalirudin) – US: The Medicines Company prevails in patent term extension dispute; USPTO acts quickly to comply with court order (Patent Docs) (Patent Docs) (IPBiz) Skelaxin (Metaxalone) – US: CAFC: Ignoring non-patentable elements while judging novelty:… [read post]
13 May 2010, 4:58 pm
Watson Pharmaceuticals Inc. et al. [read post]
24 Mar 2010, 4:45 am
Synthon Pharmaceuticals, Inc. [read post]
17 Feb 2010, 8:00 am
(patent infringement) 1/14: Daiichi Sankyo Inc.and Genzyme Corporation v. [read post]
10 Feb 2010, 4:47 pm
Mylan Pharmaceuticals Inc. [read post]
